Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
7
×
boston blog main
boston top stories
clinical trials
new york blog main
boston
new york top stories
startups
deals
fda
amgen
biogen
drug discovery
europe blog main
investing
national
novartis
ptc therapeutics
san francisco blog main
san francisco top stories
sanofi
third rock ventures
vc
venture capital
abbvie
accent therapeutics
aducanumab
alirocumab
allergan
allosteric
ally bridge group
alnylam pharmaceuticals
alzheimer's disease
amblyotech
antisense oligonucleotide
asklepios biopharmaceutical
atlas venture
What
medicines
7
×
new
7
×
fda
aims
bio
biotech
company
developing
drug
drugs
genetic
ipo
research
therapeutics
acquire
activity
address
adds
adults
ago
agreed
allergan
allosteric
analysis
approach
approvals
approved
backed
based
billion
biogen
bring
brings
called
cash
cause
ceo
cholesterol
clamped
class
Language
unset
7
×
Current search:
unset
×
new
×
medicines
×
" national top stories "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
